Media coverage
12
Media coverage
Title Lilly's Taltz (Ixekizumab) And Zepbound (Tirzepatide) Used Together Delivered Superior Efficacy In First-Of-Its-Kind Phase 3B Trial For Adults With Psoriasis And Obesity Or Overweight Media name/outlet MENAFN - Press Releases (English) Country/Territory Jordan Date 18/02/26 Persons Mark Lebwohl Title Lilly's Taltz and Zepbound used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight Media name/outlet Investing News Country/Territory Canada Date 18/02/26 URL ct.moreover.com/?a=58899145488&p=1gw&v=1&x=CFErxBFAliF2AxaeCDi-XQ Persons Mark Lebwohl Title Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight Media name/outlet ADVFN US Country/Territory United States Date 18/02/26 URL ct.moreover.com/?a=58897950405&p=1gw&v=1&x=_B8EyAukUyQ9lP2bC5g1hQ Persons Mark Lebwohl Title Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight Media name/outlet Le Lezard.com Country/Territory Canada Date 18/02/26 URL ct.moreover.com/?a=58897954980&p=1gw&v=1&x=rHosG0rhBMS2QXaS-CyOqw Persons Mark Lebwohl Title Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight | LLY Stock News Media name/outlet StockTitan.net Country/Territory United States Date 18/02/26 URL ct.moreover.com/?a=58897938862&p=1gw&v=1&x=bwGBA-WyzQYM7n8AX05b2g Persons Mark Lebwohl Title Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight Media name/outlet APNews.com Country/Territory United States Date 18/02/26 URL ct.moreover.com/?a=58897951739&p=1gw&v=1&x=gDiI74yBKXAlXfOFYQmPIw Persons Mark Lebwohl Title Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight Media name/outlet ProfitQuotes.com Country/Territory United States Date 18/02/26 URL ct.moreover.com/?a=58897929069&p=1gw&v=1&x=Uc4ZUvSkqvE94kzKLF61BA Persons Mark Lebwohl Title Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight Media name/outlet Stockwatch Country/Territory Canada Date 18/02/26 URL ct.moreover.com/?a=58897949732&p=1gw&v=1&x=UTi-R9Vu7-QyQzoSn29tNw Persons Mark Lebwohl Title Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight Media name/outlet Crwe World Country/Territory United States Date 18/02/26 URL ct.moreover.com/?a=58898042388&p=1gw&v=1&x=hHw6-Ogo5rOItMbCtv8KEg Persons Mark Lebwohl Title Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight Media name/outlet BioSpace Country/Territory United States Date 18/02/26 URL ct.moreover.com/?a=58898399474&p=1gw&v=1&x=LxgvUfoPfY3Y0qMJlopBlg Persons Mark Lebwohl Title Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight Media name/outlet Eli Lilly Country/Territory United States Date 18/02/26 URL ct.moreover.com/?a=58897975353&p=1gw&v=1&x=LPVuYcUkOc-j9v4qH8EUrA Persons Mark Lebwohl Title Eli Lilly and Company: Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight Media name/outlet FinanzNachrichten.de Country/Territory Germany Date 18/02/26 URL ct.moreover.com/?a=58901842310&p=1gw&v=1&x=DyBUpV0mabHXf1aa0FGwLg Persons Mark Lebwohl